Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Post
Print
XIAOWEN HE
Co-founder and CSO
Oricell Therapeutics Co.,Ltd
Poster(s):
(778) Chimeric Antigen Receptor-Glypican-3 T Cell Therapy CAR001 for Advanced Hepatocellular Carcinoma: a first-in-human, phase I Trial
Thursday, April 16, 2026
2:30 PM - 3:30 PM
US ET
(786) Ori-TTV particles enable potent in vivo CAR-T cell engineering for the treatment of hematologic malignancies and autoimmune diseases.
Saturday, April 18, 2026
2:30 PM - 3:30 PM
US ET
